MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Identification of genetic alterations and SNCA mutation in Parkinson’s disease patients of Coimbatore Population, India

    D. Venkatesan, B. Vellingiri (Coimbatore, India)

    Objective: The aim of the study is to analyze the genetic alterations in SNCA gene and dopamine transporter in 22 PD patients of Coimbatore population.…
  • 2019 International Congress

    Wislon disease: clinical specificities of the disease course under normal ceruloplasmin in the blood, a clinical case from Kyrgyzstan

    N. Chekeeva (Bishkek, Kyrgyzstan)

    Objective: Apparent clinical picture of Wilson's disease with normal blood ceruloplasmin levels in young patients with Wilson's disease. Background: Wilson's disease is a hereditary disease…
  • 2019 International Congress

    Dysphagia in Adults with Niemann-Pick Disease Type C

    C. Lewis, M. Walterfang, A. Vogel (Melbourne, Australia)

    Objective: We aimed to (1) characterise baseline swallow function in people with NPC and (2) evaluate the impact of Miglustat treatment on the swallowing process.…
  • 2019 International Congress

    X-chromosomal Dystonia-Parkinsonism: a systematic review of published and unpublished clinical data

    M. Pauly, M. Ruiz López, H. Madoev, R. Rosales, C. Diesta, R. Jamora, S. Petkovic, N. Brüggemann, A. Westenberger, C. Klein, A. Domingo (Lübeck, Germany)

    Objective: To summarize and curate all published clinical data on x-chromosomal dystonia-parkinsonism (XDP) patients; identify relevant researches working on XDP and contact them for additional…
  • 2019 International Congress

    TFEB-driven expression prevents neurodegeneration in a multiple system atrophy mouse model

    ML. Arotcarena, M. Bourdenx, N. Dutheil, ML. Thiolat, E. Doudnikoff, S. Dovero, A. Ballabio, PO. Fernagut, W. Meissner, E. Bezard, B. Dehay (Bordeaux, France)

    Objective: To explore the potential neuroprotective effects of overexpressing the transcription factor EB in a MSA mouse model . Background: Synucleinopathies are neurodegenerative diseases characterized…
  • 2019 International Congress

    Prevalence of Rem Behavior Disorder (RBD) in different motor subtypes of Parkinson`s Disease corroborated by Polisomnography

    O. Cardenas, A. Abundes, M. Rodríguez, A. Cervantes, V. Alatriste (Mexico City, Mexico)

    Objective: The objective is to compare the prevalence of RBD in the different motor subtypes of Parkinson`s disease (PD), using polysomnography as the gold standard.…
  • 2019 International Congress

    Profiling of lipoproteins and associated lipids in serum samples from Idiopathic REM Sleep Behavior Disorder patients to identify biomarkers for Parkinson’s disease

    A. Laguna, A. Iranzo, M. Serradell, N. Amigó, O. Yanes, M. Vila (Barcelona, Spain)

    Objective: To perform a lipidomic profile in serum samples from IRBD patients collected before and after their conversion to PD and DLB, in order to…
  • 2019 International Congress

    People with Parkinson’s Disease (PPD): disease, stigma and the others

    M. Bacigalupe (La Plata, Argentina)

    Objective: To show what does it mean to be PPD and the relationship with their environment from the point of view of the participants. Background:…
  • 2019 International Congress

    Complex disease burden in Parkinson’s and Advance Care Planning

    M. Khwaja, A. Chatterjee, G. Alg, A. Cotton, L. Richardson, H. Avery (Reading, United Kingdom)

    Objective: To evaluate if Advanced Care Planning is completed in patients with complex stage of Parkinson’s Disease (PD). Background: NICE (National Institute of Health and…
  • 2019 International Congress

    Difference in perception of the wearing-off between patients and physicians in Parkinson’s disease

    Y. Tsuboi, R. Nakagawa, M. Ishido, Y. Yoshinaga, T. Hashimoto, T. Mishima, S. Fujioka (Fukuoka, Japan)

    Objective: To explore if any inconsistency exists in the perception of the presence of wearing-off (WO) symptoms between patients and physicians in Parkinson’s disease (PD).…
  • « Previous Page
  • 1
  • …
  • 97
  • 98
  • 99
  • 100
  • 101
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley